Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALIMERA SCIENCES INC ALIMERA SCIENCES
Updated on 15 Oct 2019 (End of trading day)
Last (USD): 0.400 Change: +0.010 High: 0.402 Remarks: -
Change (%): +2.67 Low: 0.360
Open 0.389 Yesterday's Close 0.3896
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 223,961 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.23070 Trailing EPS (USD) e 0.26361 NAV (USD) b -0.4792
PE a - Trailing PE f 1.517 Price / NAV b -0.8347
Dividend (USD) d - Cash In Hand (USD) g 0.1717 Issued & Paid-up Shares c 71,009,000
Dividend Yield (%) d - Price / Cash In Hand g 2.330 Treasury Shares h -
Beta - 75 Daysi 0.602 R-Squared - 75 Days(%)i 0.93 Market Cap (M) 28.404
Beta - 500 Daysi 0.128 R-Squared - 500 Days (%)i 0.12 Enterprise Value (M) 86.762
Piotroski F Score 2 Exchange Code ALIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 72.41 Free Float (%) 83.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALIMERA SCIENCES INC NASDAQ 28.404 - 1.517 -0.8347 -
Industry Biotechnology NASDAQ 2,170.255 133.135 101.971 5.1053 0.808
Local Peer AMGEN INC NASDAQ 122,734.807 14.622 15.423 11.3706 2.709
Local Peer GILEAD SCIENCES INC NASDAQ 82,699.185 15.160 13.887 3.6567 3.534
Local Peer CELGENE CORP NASDAQ 71,547.404 17.684 13.574 7.1184 -
Local Peer ILLUMINA INC NASDAQ 45,888.990 55.556 48.922 10.5930 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 45,274.145 21.596 20.440 8.9299 -
Local Peer BIOGEN INC NASDAQ 41,696.089 9.411 7.876 3.2191 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,388.101 13.659 16.135 3.4223 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,501.232 302.849 17.622 2.3123 -
Local Peer INCYTE CORPORATION NASDAQ 16,887.061 154.230 55.210 7.5147 -
Local Peer SEATTLE GENETICS INC NASDAQ 14,079.797 - - 11.0705 -
Local Peer EXACT SCIENCES CORP NASDAQ 12,914.834 - - 16.8705 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 12,295.010 - - 4.1524 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), 10X GENOMICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KODIAK SCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CORTEXYME INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), DERMIRA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARDELYX INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), RESTORBIO INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SERES THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), IMV INC (NASDAQ), NANTKWEST INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NOVAVAX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), CHIMERIX INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), VERASTEM INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ARAVIVE INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SAVARA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONTRAFECT CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VAXART INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 114,826.327 42.799 42.799 15.3447 1.049
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,442.201 74.184 21.868 4.9383 0.808
Global Peer SINO BIOPHARM HKEx 142,093.171 13.261 13.686 4.1745 0.648
Global Peer WUXI BIO HKEx 101,201.433 135.494 105.925 10.4175 -
Global Peer BEIGENE HKEx 58,681.498 - - 4.8339 -
Global Peer 3SBIO HKEx 34,983.414 23.126 28.148 3.4480 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 29,063.268 174.790 - 8.1959 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,798.268 44.629 - 2.8297 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), CKLIFE SCIENCES (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), KADMON HLDGS INC (NYSE), LEE'S PHARM (HKEx), NEXT SCIENCE LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), PFENEX INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NANOVIRICIDES INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), PHYLOGICA LIMITED (ASX), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PORT (SET), IMUGENE LIMITED (ASX), CT ENTERPRISE (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), BIONOMICS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IBIO INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ISORAY INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), IMMURON LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), Suntar Eco-City^ (SGX), GENETIC TECHNOLOGIES (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CELLMID LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MEDIBIO LIMITED (ASX), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), MEGASUN (Bursa), TBG DIAGNOSTICS LTD (ASX), QT Vascular (SGX), CCP TECHNOLOGIES LTD (ASX), NOVITA HEALTHCARE LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.040
-9.09 %
20 Days --0.022
-5.21 %
Medium Term Return 3 Months --0.458
-53.38 %
6 Months --0.559
-58.29 %
1 Year --0.560
-58.33 %
Long Term Return 2 Years --0.930
-69.92 %
3 Years --0.940
-70.15 %
5 Years --4.410
-91.68 %
Annualised Return Annualised --
-39.19 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.321 - 1.210 Change From 1 Year Low +0.079 % Change From 1 Year Low (%) +24.61
Change From 1 Year High -0.810 % Change From 1 Year High (%) -66.94
2 Years Range 0.321 - 1.400 Change From 2 Years Low +0.079 % Change From 2 Years Low (%) +24.61
Change From 2 Years High -1.000 % Change From 2 Years High (%) -71.43
5 Years Range 0.321 - 6.360 Change From 5 Years Low +0.079 % Change From 5 Years Low (%) +24.61
Change From 5 Years High -5.960 % Change From 5 Years High (%) -93.71
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2019 0.389 0.402 0.360 0.400 223,961 -
14 Oct 2019 0.400 0.418 0.375 0.390 88,337 -
11 Oct 2019 0.416 0.428 0.390 0.400 125,318 -
10 Oct 2019 0.402 0.418 0.396 0.408 258,846 -
09 Oct 2019 0.401 0.423 0.396 0.400 150,658 -
08 Oct 2019 0.423 0.449 0.390 0.400 234,847 -
07 Oct 2019 0.440 0.450 0.410 0.427 229,629 -
04 Oct 2019 0.439 0.450 0.373 0.413 338,206 -
03 Oct 2019 0.425 0.440 0.371 0.438 765,881 -
02 Oct 2019 0.500 0.500 0.440 0.440 369,936 -
01 Oct 2019 0.575 0.575 0.453 0.490 507,889 -
30 Sep 2019 0.532 0.581 0.480 0.566 964,623 -
27 Sep 2019 0.548 0.570 0.520 0.529 84,023 -
26 Sep 2019 0.564 0.600 0.535 0.549 393,750 -
25 Sep 2019 0.532 0.620 0.532 0.560 390,981 -
24 Sep 2019 0.622 0.690 0.514 0.530 729,050 -
23 Sep 2019 0.502 0.630 0.500 0.601 701,301 -
20 Sep 2019 0.465 0.500 0.441 0.500 248,117 -
19 Sep 2019 0.425 0.470 0.425 0.469 287,375 -
18 Sep 2019 0.414 0.450 0.400 0.422 126,407 -
17 Sep 2019 0.422 0.445 0.400 0.411 84,518 -
16 Sep 2019 0.408 0.461 0.408 0.420 1,747,666 -
Summary
Current 2 Weeks
(02 Oct 2019 to 15 Oct 2019)
0.500 0.500 0.360 0.400 2,785,619 -
Previous 2 Weeks
(18 Sep 2019 to 01 Oct 2019)
0.414 0.500 0.360 0.490 4,433,516 -
4 Weeks from
(20 Aug 2019 to 17 Sep 2019)
0.481 0.508 0.360 0.412 5,763,189 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.